179 related articles for article (PubMed ID: 23364479)
1. The hematopoietic stem cell regulatory gene latexin has tumor-suppressive properties in malignant melanoma.
Muthusamy V; Premi S; Soper C; Platt J; Bosenberg M
J Invest Dermatol; 2013 Jul; 133(7):1827-33. PubMed ID: 23364479
[TBL] [Abstract][Full Text] [Related]
2. Latexin expression is downregulated in human gastric carcinomas and exhibits tumor suppressor potential.
Li Y; Basang Z; Ding H; Lu Z; Ning T; Wei H; Cai H; Ke Y
BMC Cancer; 2011 Apr; 11():121. PubMed ID: 21466706
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic silencing of novel tumor suppressors in malignant melanoma.
Muthusamy V; Duraisamy S; Bradbury CM; Hobbs C; Curley DP; Nelson B; Bosenberg M
Cancer Res; 2006 Dec; 66(23):11187-93. PubMed ID: 17145863
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) in malignant cutaneous melanoma.
Spugnardi M; Tommasi S; Dammann R; Pfeifer GP; Hoon DS
Cancer Res; 2003 Apr; 63(7):1639-43. PubMed ID: 12670917
[TBL] [Abstract][Full Text] [Related]
5. Latexin inhibits the proliferation of CD133+ miapaca-2 pancreatic cancer stem-like cells.
Xue ZX; Zheng JH; Zheng ZQ; Cai JL; Ye XH; Wang C; Sun WJ; Zhou X; Lu MD; Li PH; Cai ZZ
World J Surg Oncol; 2014 Dec; 12():404. PubMed ID: 25551472
[TBL] [Abstract][Full Text] [Related]
6. Bone Microenvironment Changes in Latexin Expression Promote Chemoresistance.
Zhang M; Osisami M; Dai J; Keller JM; Escara-Wilke J; Mizokami A; Keller ET
Mol Cancer Res; 2017 Apr; 15(4):457-466. PubMed ID: 28087740
[TBL] [Abstract][Full Text] [Related]
7. Latexin Inactivation Enhances Survival and Long-Term Engraftment of Hematopoietic Stem Cells and Expands the Entire Hematopoietic System in Mice.
Liu Y; Zhang C; Li Z; Wang C; Jia J; Gao T; Hildebrandt G; Zhou D; Bondada S; Ji P; St Clair D; Liu J; Zhan C; Geiger H; Wang S; Liang Y
Stem Cell Reports; 2017 Apr; 8(4):991-1004. PubMed ID: 28330618
[TBL] [Abstract][Full Text] [Related]
8. The putative tumour suppressor protein Latexin is secreted by prostate luminal cells and is downregulated in malignancy.
Seed RI; Taurozzi AJ; Wilcock DJ; Nappo G; Erb HHH; Read ML; Gurney M; Archer LK; Ito S; Rumsby MG; Petrie JL; Clayton A; Maitland NJ; Collins AT
Sci Rep; 2019 Mar; 9(1):5120. PubMed ID: 30914656
[TBL] [Abstract][Full Text] [Related]
9. Latexin is down-regulated in hematopoietic malignancies and restoration of expression inhibits lymphoma growth.
Liu Y; Howard D; Rector K; Swiderski C; Brandon J; Schook L; Mehta J; Bryson JS; Bondada S; Liang Y
PLoS One; 2012; 7(9):e44979. PubMed ID: 23028717
[TBL] [Abstract][Full Text] [Related]
10. Latexin exhibits tumor-suppressor potential in pancreatic ductal adenocarcinoma.
Xue Z; Zhou Y; Wang C; Zheng J; Zhang P; Zhou L; Wu L; Shan Y; Ye M; He Y; Cai Z
Oncol Rep; 2016 Jan; 35(1):50-8. PubMed ID: 26530530
[TBL] [Abstract][Full Text] [Related]
11. Elevated osteopontin levels in metastatic melanoma correlate with epigenetic silencing of breast cancer metastasis suppressor 1.
Metge BJ; Liu S; Riker AI; Fodstad O; Samant RS; Shevde LA
Oncology; 2010; 78(1):75-86. PubMed ID: 20215788
[TBL] [Abstract][Full Text] [Related]
12. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T
Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735
[TBL] [Abstract][Full Text] [Related]
13. KLF6 Gene and early melanoma development in a collagen I-rich extracellular environment.
Huh SJ; Chen YL; Friedman SL; Liao J; Huang HJ; Cavenee WK; Robertson GP
J Natl Cancer Inst; 2010 Aug; 102(15):1131-47. PubMed ID: 20660366
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic loss of the familial tumor-suppressor gene exostosin-1 (EXT1) disrupts heparan sulfate synthesis in cancer cells.
Ropero S; Setien F; Espada J; Fraga MF; Herranz M; Asp J; Benassi MS; Franchi A; Patiño A; Ward LS; Bovee J; Cigudosa JC; Wim W; Esteller M
Hum Mol Genet; 2004 Nov; 13(22):2753-65. PubMed ID: 15385438
[TBL] [Abstract][Full Text] [Related]
15. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.
Koutsimpelas D; Pongsapich W; Heinrich U; Mann S; Mann WJ; Brieger J
Oncol Rep; 2012 Apr; 27(4):1135-41. PubMed ID: 22246327
[TBL] [Abstract][Full Text] [Related]
16. Dipeptidyl peptidase IV (DPPIV), a candidate tumor suppressor gene in melanomas is silenced by promoter methylation.
McGuinness C; Wesley UV
Front Biosci; 2008 Jan; 13():2435-43. PubMed ID: 17981724
[TBL] [Abstract][Full Text] [Related]
17. Use of integrative epigenetic and cytogenetic analyses to identify novel tumor-suppressor genes in malignant melanoma.
Mithani SK; Smith IM; Califano JA
Melanoma Res; 2011 Aug; 21(4):298-307. PubMed ID: 21606880
[TBL] [Abstract][Full Text] [Related]
18. Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas.
Reifenberger J; Knobbe CB; Sterzinger AA; Blaschke B; Schulte KW; Ruzicka T; Reifenberger G
Int J Cancer; 2004 Apr; 109(3):377-84. PubMed ID: 14961576
[TBL] [Abstract][Full Text] [Related]
19. Latexin sensitizes leukemogenic cells to gamma-irradiation-induced cell-cycle arrest and cell death through Rps3 pathway.
You Y; Wen R; Pathak R; Li A; Li W; St Clair D; Hauer-Jensen M; Zhou D; Liang Y
Cell Death Dis; 2014 Oct; 5(10):e1493. PubMed ID: 25341047
[TBL] [Abstract][Full Text] [Related]
20. Profiling epigenetic inactivation of tumor suppressor genes in tumors and plasma from cutaneous melanoma patients.
Hoon DS; Spugnardi M; Kuo C; Huang SK; Morton DL; Taback B
Oncogene; 2004 May; 23(22):4014-22. PubMed ID: 15064737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]